All material subject to strictly enforced copyright laws. © 2021 Euromoney Institutional Investor PLC group
EquityABBs-Block Trades

argenx sells $1bn of stock

argenx_PA_575_375

Dutch biotech firm argenx has tapped equity investors for $1bn (€830.3m) to finance research and development.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree